Induction of apoptosis and growth inhibition by silodosin and abiraterone acetate in PC-3 human prostate cancer cells

Purpose: Prostate cancer that progresses despite androgen deprivation therapy, known as metastatic castration-resistant prostate cancer (mCRPC) is notoriously difficult to treat. While abiraterone acetate (AA) is a standard therapy, repurposing drugs like silodosin, a selective α1A-adrenoceptor anta...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lukman Hakim, Zakaria Aulia Rahman, Furqan Hidayatullah, Anthony Chi-Fai Ng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Urological Association 2025-11-01
coleção:	Investigative and Clinical Urology
Assuntos:	abiraterone acetate in vitro techniques prostatic neoplasms silodosin
Acesso em linha:	https://www.icurology.org/pdf/10.4111/icu.20250310
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!